A recent study has identified a link between the type 2 diabetes medication Actos (generic: pioglitazone) and pancreatic cancer, a disease that kills more than 40,000 Americans each year.
Free Confidential Lawsuit Evaluation: If you or a loved one was diagnosed with pancreatic cancer after taking Actos, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help.
What’s the Problem?
The study, titled Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes, looked at long-term data from nearly 200,000 patients with type 2 diabetes. A research team led by Dr. Assiamira Ferrara at Kaiser Permanente Northern California found no evidence suggesting Actos may raise users’ risk of developing bladder cancer (a disease linked to the drug in earlier studies); however, after analyzing data from another group of more than 236,000 diabetes patients, the researchers did find that Actos use was associated with a 40% increased risk of pancreatic cancer.
The study’s authors cautioned additional research is needed to investigate the matter, and that it’s difficult to conclude from this study that Actos causes pancreatic cancer since inflammation is a key risk factor for the disease and chronic inflammation is common in people with diabetes. The study was funded by Takeda Pharmaceuticals, the company that makes Actos, and published in the July 21 edition of the Journal of the American Medical Association (JAMA).
Pancreatic Cancer Symptoms
- Abdominal pain
- Pale-colored stools
- Dark urine
- Weight loss
After pancreatic cancer is diagnosed and staged, the patient and their doctor will discuss potential treatment options. The benefits of each option should be weighed against the possible risks and side effects. Two of the main factors to consider are whether the cancer can be removed with surgery and the patient’s overall health.
The main types of treatment for pancreatic cancer are:
- Ablative techniques
- Radiation therapy
- Chemotherapy and other drugs
Actos Settlement Shaky as Deadline Approaches
Takeda’s proposed $2.37 billion settlement of Actos bladder cancer lawsuits didn’t attract enough takers by the August 12, 2015 deadline to move forward, raising concerns that the deal will fall through. Takeda must fund the settlement after 95% of plaintiffs join it; however, by August 12 only about 75% had agreed to the deal, so the deadline was postponed to September 11. Click here to learn more.
Do I Have an Actos Pancreatic Cancer Lawsuit?
The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Actos Lawsuits. We are handling individual litigation nationwide and currently accepting new pancreatic cancer cases in all 50 states.
Free Confidential Case Evaluation: Again, if you or a loved one developed pancreatic cancer after using Actos, you should contact our law firm immediately. You may be entitled to compensation by filing a suit and our lawyers can help.